1. Introduction: A surgical strategy for optimizing breast cancer therapy

   • Laura Esserman
   • Kirby I. Bland

   OriginalPaper Pages: 1S - 2S

2. Neoadjuvant chemotherapy for primary breast cancer: Lessons learned and opportunities to optimize therapy

   • Laura Esserman

   OriginalPaper Pages: 3S - 8S

3. Importance of correlative science in advancing hormonal therapy and a new clinical paradigm for neoadjuvant therapy

   • Matthew J. Ellis

   OriginalPaper Pages: 9S - 17S

4. Role of endocrine therapy in the neoadjuvant surgical setting

   • J. Michael Dixon

   OriginalPaper Pages: 18S - 23S

5. The role of clinical trials in changing therapy for ductal carcinoma in situ

   • William C. Wood

   OriginalPaper Pages: 24S - 27S

6. Applying the neoadjuvant paradigm to ductal carcinoma in situ

   • Laura Esserman
   • Karen Sepucha
   • E. Shelley Hwang

   OriginalPaper Pages: 28S - 36S

7. Neoadjuvant hormonal therapy for ductal carcinoma in situ: Trial design and preliminary results

   • E. Shelley Hwang
   • Laura Esserman

   OriginalPaper Pages: 37S - 43S